Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Clinical Investigation
Volume130
StatePublished - Feb 3 2020

Cite this